FDA Issues New Safety Alert for Miacalcin (Calcitonin)

FDA Center for Drug Evaluation and Research (CDER) issued a new safety labeling change for Miacalcin (Calcitonin-Salmon) Nasal Spray and Injection. Tremors were added as an adverse reaction.

The accompanying product information that you receive with your prescription will have the following addition:


  • Dermatologic/Hypersensitivity
  • Central and Peripheral Nervous System:
  • Tremor

Source: FDA.govĀ